- Home
- Equipment
- australasia
- drug delivery
Show results for
Refine by
Drug Delivery Equipment Supplied In Australasia
11 equipment items found
Manufactured by:Renishaw plc based inGloucestershire, UNITED KINGDOM
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
Starpharma’s DEP® technology provides enhanced therapeutic benefits to Antibody Drug Conjugates (ADCs) including greater homogeneity, site specific attachment, and higher drug antibody ratio (DAR), than conventional ADC approaches. The use of ADCs is an innovative and cutting-edge area in cancer therapy that continues to grow, and Starpharma has a number of partner programs in the area. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug used to treat colorectal cancer with peak global ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” warnings. DEP® docetaxel is a detergent free, aqueous formulation of docetaxel. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® radiotheranostic conjugates have the potential to minimise off-target toxicity, optimise pharmacokinetics and enhance efficacy when used alone or in combination with other therapeutic approaches. The versatility of Starpharma’s DEP® platform means it can be used with a wide range of therapies and types of molecules (e.g., small molecule drugs, peptides, antibodies, ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
Manufactured by:PolyActiva Pty Ltd. based inParkville, AUSTRALIA
For development of best-in-class ocular implants that deliver the right amount of drug, for the right period. Our technology is based on extensive scientific research leveraging our expertise in pharmaceutical, organic and polymer chemistry. The result is the creation of a unique method for precise and controlled drug delivery. Since many eye ...
Manufactured by:Botanix Pharmaceuticals based inNorth Perth, AUSTRALIA
The skin’s role is to protect the body from a range of chemical and environmental assaults, so bypassing this active system requires an innovative approach. Botanix has exclusively licensed a novel transdermal drug delivery solution known as Permetrex™, which is designed to deliver pharmaceuticals through the skin more effectively. Right to where ...
Manufactured by:Avania based inBrunswick, AUSTRALIA
Preserving or restoring eyesight has the power to change a patient’s life. Avania’s ophthalmology team works with you to advance your important research that is necessary for better eye health. From medical technologies to medical devices and diagnostic development, we are your partner with the strategic guidance that allows you to reach better clinical outcomes and expedite your ...
Manufactured by:Glaukos Corporation based inSan Clemente, CALIFORNIA (USA)
iStent inject® W is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate primary open-angle ...